Skip to main content

Advertisement

SpringerLink
Log in

Clinical utility of CorVue intrathoracic impedance alert with device-measured physical activity in predicting heart failure events

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Cardiac implantable electronic devices (CIEDs) offer heart failure (HF) diagnostic information, including intrathoracic impedance (ITI) or physical activity (PA). However, few studies have evaluated the utility of these parameters measured by CIEDs with CorVue algorithm. The purpose of this study was to investigate the relationship between ITI alerts triggered by the CorVue algorithm and HF development. We also examined the association between device-measured PA and ITI alerts associated with HF development. We retrospectively studied consecutive patients with CIEDs equipped with CorVue algorithm, which were implanted between June 1, 2011 and August 31, 2019. These patients were divided into two groups: patients with decreased ITI followed by the ITI alerts (ITI alert group) and those without the alerts (non-ITI alert group). There were 35 and 14 patients in the ITI and non-ITI alert groups, respectively. A total of 96 ITI alerts were observed. ITI alerts associated with HF development were observed in 21% (20/96); whereas, ITI alerts not associated with HF development were observed in 79% (76/96). Accurate device-measured PA was confirmed in 76 ITI alerts, which consisted of 30 alerts with lower PA and 46 alerts without lower PA. ITI alerts associated with HF development were observed in 30% (9/30) of the alerts with lower PA, whereas observed only in 6.5% (3/46) of the alerts without lower PA. In conclusion, the CorVue ITI alerts indicated a high false-positive rate. However, device-measured PA may be useful to determine whether ITI alerts are associated with HF development or not, which was attributed to the high negative predictive value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, Van Der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200m

    Article  Google Scholar 

  2. Yu CM, Wang L, Chau E, Chan RHW, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP (2005) Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112:841–848

    Article  Google Scholar 

  3. Van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Muñoz Aguilera R, Lunati M, Yu CM, Gerritse B, Borggrefe M (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124:1719–1726

    Article  Google Scholar 

  4. Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR (2011) Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 32:2266–2273

    Article  Google Scholar 

  5. Palfy JA, Benezet-Mazuecos J, Martinez Milla J, Iglesias JA, de la Vieja JJ, Sanchez-Borque P, Miracle A, Rubio JM (2018) CorVue algorithm efficacy to predict heart failure in real life: unnecessary and potentially misleading information? Pacing Clin Electrophysiol 41:948–952

    Article  Google Scholar 

  6. Blair SN, Kohl HW, Barlow CE, Paffenbarger RS, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273:1093–1098

    Article  CAS  Google Scholar 

  7. Myers J, Prakash M, Froelicher V, Do D, Partington S, Edwin Atwood J (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801

    Article  Google Scholar 

  8. Conraads VM, Spruit MA, Braunschweig F, Cowie MR, Tavazzi L, Borggrefe M, Hill MRS, Jacobs S, Gerritse B, Van Veldhuisen DJ (2014) Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circ Hear Fail 7:279–287

    Article  Google Scholar 

  9. Kramer DB, Mitchell SL, Monteiro J, Jones PW, Normand SL, Hayes DL, Reynolds MR (2015) Patient activity and survival following implantable cardioverter-defibrillator implantation: the ALTITUDE activity study. J Am Heart Assoc 4:e001775

    PubMed  PubMed Central  Google Scholar 

  10. Vegh EM, Kandala J, Orencole M, Upadhyay GA, Sharma A, Miller A, Merkely B, Parks KA, Singh JP (2014) Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol 113:1523–1528

    Article  Google Scholar 

  11. Mckee PA, Castelli WP, Mcnamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446

    Article  CAS  Google Scholar 

  12. Forleo GB, Panattoni G, Schirripa V, Papavasileiou LP, Della Rocca DG, Politano A, Ticconi F, Biscione C, Sergi D, Di Molfetta A, Santini L, Capria A, Romeo F (2013) Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system. J Cardiovasc Med 14:726–732

    Article  Google Scholar 

  13. Domenichini G, Rahneva T, Diab IG, Dhillon OS, Campbell NG, Finlay MC, Baker V, Hunter RJ, Earley MJ, Schilling RJ (2016) The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study). Europace 18:428–435

    Article  Google Scholar 

  14. Keteyian SJ, Leifer ES, Houston-Miller N, Kraus WE, Brawner CA, O’Connor CM, Whellan DJ, Cooper LS, Fleg JL, Kitzman DW, Cohen-Solal A, Blumenthal JA, Rendall DS, Piña IL (2012) Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol 60:1899–1905

    Article  Google Scholar 

  15. Kramer DB, Tsai T, Natarajan P, Tewksbury E, Mitchell SL, Travison TG (2017) Frailty, physical activity, and mobility in patients with cardiac implantable electrical devices. J Am Heart Assoc 6:e004659

    PubMed  PubMed Central  Google Scholar 

  16. Rosman L, Lampert R, Sears SF, Burg MM (2018) Measuring physical activity with implanted cardiac devices: a systematic review. J Am Heart Assoc 7:e008663

    Article  Google Scholar 

  17. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O’Connor CM (2010) Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations. results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) Study. J Am Coll Cardiol 55:1803–1810

    Article  Google Scholar 

  18. Sharma V, Rathman LD, Small RS, Whellan DJ, Koehler J, Warman E, Abraham WT (2015) Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds. Hear Lung 44:129–136

    Article  Google Scholar 

  19. Vamos M, Nyolczas N, Bari Z, Bogyi P, Muk B, Szabo B, Ancsin B, Kiss RG, Duray GZ (2018) Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients. Cardiol J 25:236–244

    PubMed  Google Scholar 

  20. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 122:2359–2367

    Article  Google Scholar 

  21. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Søgaard P (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384:583–590

    Article  Google Scholar 

  22. Jamé S, Kutyifa V, Polonsky B, McNitt S, Al-Ahmad A, Moss AJ, Zareba W, Wang PJ (2017) Predictive value of device-derived activity level for short-term outcomes in MADIT-CRT. Hear Rhythm 14:1081–1086

    Article  Google Scholar 

  23. Kelly JP, Ballew NG, Lin L, Hammill BG, Stivland TM, Jones PW, Curtis LH, Hernandez AF, Greiner MA, Atwater BD (2020) Association of implantable device measured physical activity with hospitalization for heart failure. JACC Hear Fail 8:280–288

    Article  Google Scholar 

Download references

Funding

This research received no grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Matsumoto Kyoritsu Hospital, 9-26 Habaue, Matsumoto City, Nagano, 390-8505, Japan

    Yasushi Wakabayashi, Masanori Kobayashi, Tomohide Ichikawa, Takashi Koyama & Hidetoshi Abe

Authors
  1. Yasushi Wakabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masanori Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohide Ichikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hidetoshi Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasushi Wakabayashi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wakabayashi, Y., Kobayashi, M., Ichikawa, T. et al. Clinical utility of CorVue intrathoracic impedance alert with device-measured physical activity in predicting heart failure events. Heart Vessels 36, 1166–1174 (2021). https://doi.org/10.1007/s00380-021-01790-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-01790-6

Keywords

Search

Navigation